LENZ Therapeutics (LENZ) Depreciation and Depletion (2020 - 2023)
LENZ Therapeutics' (LENZ) quarterly Depreciation and Depletion came in at $100000.0 in Q4 2023, down 85.71% year-on-year from $700000.0 in Q4 2022, and down 87.5% on a QoQ basis from $800000.0 in Q3 2023.
LENZ Therapeutics (LENZ) Depreciation and Depletion (2020 - 2023) Analysis & Trends
LENZ Therapeutics (LENZ) has 4 years of Depreciation and Depletion data on file, last reported at $100000.0 in Q4 2023.
- On a quarterly basis, Depreciation and Depletion fell 85.71% year-over-year to $100000.0 in Q4 2023; TTM through Dec 2023 was $2.4 million, a 0.0% change from a year earlier, with the FY2023 full-year figure at $2.4 million, changed 0.0% from the prior year.
- Depreciation and Depletion for Q4 2023 stood at $100000.0, down from $800000.0 in the prior quarter.
- Over the last five years, Depreciation and Depletion for LENZ reached as high as $800000.0 in Q2 2023 and fell as low as $1000.0 in Q2 2020.
- Historically, Depreciation and Depletion has averaged $400071.4 across 4 years, with a median of $350000.0 in 2021.
- Across the five-year window, Depreciation and Depletion soared 9900.0% in 2021 and slumped 85.71% in 2023, its largest moves.
- Year by year, Depreciation and Depletion stood at $100000.0 in 2020, then jumped by 200.0% to $300000.0 in 2021, then surged by 133.33% to $700000.0 in 2022, then sank by 85.71% to $100000.0 in 2023.
- Per Business Quant data, the three most recent Depreciation and Depletion figures were $100000.0 in Q4 2023, $800000.0 in Q3 2023, and $800000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | LENZ Therapeutics | 158.34 Mn | 158.34 Mn | 825,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | 800,000.00 |
| Sep 30, 2023 | 800,000.00 |
| Jun 30, 2023 | 800,000.00 |
| Jun 30, 2023 | 800,000.00 |
| Mar 31, 2023 | 700,000.00 |
| Mar 31, 2023 | 700,000.00 |
| Dec 31, 2022 | 700,000.00 |
| Dec 31, 2022 | 700,000.00 |
| Sep 30, 2022 | 700,000.00 |
| Sep 30, 2022 | 700,000.00 |
| Jun 30, 2022 | 600,000.00 |
| Jun 30, 2022 | 600,000.00 |
| Mar 31, 2022 | 400,000.00 |
| Mar 31, 2022 | 400,000.00 |
| Dec 31, 2021 | 300,000.00 |
| Dec 31, 2021 | 300,000.00 |
| Sep 30, 2021 | 200,000.00 |
| Sep 30, 2021 | 200,000.00 |